Telix initiates first-in-human study of next-generation prostate cancer therapy candidate TLX-592 Aug. 5, 2021
89Zr-Immuno-PET using bispecific Abeta MAb as promising diagnostic strategy for Alzheimer's disease Aug. 5, 2021
Target engagement, safety seen with anti-TREM-2 monoclonal antibody AL-002 in healthy subjects Aug. 5, 2021
Exosomes conjugated to VEGF antibodies show efficacy in models of choroidal neovascularization Aug. 5, 2021
The University of Washington and the Department of Veterans Affairs patent glycolysis inhibitors Aug. 5, 2021
RSS